scispace - formally typeset
P

Patrick Santens

Researcher at Ghent University Hospital

Publications -  230
Citations -  8521

Patrick Santens is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Parkinson's disease & Frontotemporal lobar degeneration. The author has an hindex of 43, co-authored 218 publications receiving 7840 citations. Previous affiliations of Patrick Santens include Ghent University.

Papers
More filters
Journal ArticleDOI

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

TL;DR: It is demonstrated that FTDU-17 is caused by mutations in the gene coding for progranulin (PGRN), a growth factor involved in multiple physiological and pathological processes including tumorigenesis, and evidence that P GRN haploinsufficiency leads to neurodegeneration because of reduced PGRN-mediated neuronal survival is provided.
Journal ArticleDOI

Multisubject learning for common spatial patterns in motor-imagery BCI

TL;DR: The details of the multitask CSP algorithm are outlined, results on two data sets are shown and a clear improvement can be seen, especially when the number of training trials is relatively low.
Journal ArticleDOI

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.

TL;DR: Clinicians should consider changing to a non-ergot drug if this disease is diagnosed, and pergolide treatment was stopped because of restrictive valvular heart disease, in six patients, in two of whom regression of disease was shown.
Journal ArticleDOI

A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats

Julie van der Zee, +88 more
- 01 Feb 2013 - 
TL;DR: In vitro reporter gene expression studies demonstrated significantly decreased transcriptional activity of C9orf72 with increasing number of normal repeat units, indicating that intermediate repeats might act as predisposing alleles and in favor of the loss‐of‐function disease mechanism.